5-hydroxytryptamine receptor 1A
mammalian protein found in Homo sapiens
found in taxon
amgodiwyd gan
HTR1A[8]
swyddogaeth moleciwlaidd
rhan o'r gell
proses fiolegol
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger[20]
dull penderfynu: IBA
adweithia'n ffisegol gyda
yn cynnwys
GPCR, rhodopsin-like, 7TM[9]
categori Comin
5-HT1A serotonin receptor
prif gategori
Category:5-HT1A serotonin receptor
Cyfeiriadau
- ↑ NCBI Gene, 30 Mai 2020, 3350
- ↑ Transporter Classification database, 13 Mawrth 2020
- ↑ Transporter Classification database, 29 Ebrill 2020
- ↑ https://www.wikidata.org/w/index.php?title=Wikidata:Property_proposal/Guide_to_Pharmacology_Target_ID&oldid=709819452
- ↑ OpenAlex, 26 Ionawr 2022, https://docs.openalex.org/download-snapshot/snapshot-data-format
- ↑ Ensembl Release 99, ENSP00000316244
- ↑ Ensembl Release 99, ENSP00000423433
- ↑ 8.0 8.1 8.2 8.3 UniProt, 13 Tachwedd 2019, P08908
- ↑ 9.0 9.1 InterPro Release 71.0, http://www.ebi.ac.uk/interpro/protein/P08908
- ↑ inferred from protein domain or family
- ↑ IEA, 16 Gorffennaf 2018, P08908, GOA, http://www.ebi.ac.uk/QuickGO/annotations?protein=P08908&geneProductId=UniProtKB:P08908, UniProt
- ↑ 12.0 12.1 12.2 IEA, http://www.ebi.ac.uk/QuickGO/annotations?protein=P08908&geneProductId=UniProtKB:P08908, 16 Gorffennaf 2018, InterPro, GOA
- ↑ IEA, 1 Ionawr 2018, P08908, GOA, http://www.ebi.ac.uk/QuickGO/annotations?protein=P08908&geneProductId=UniProtKB:P08908, UniProt
- ↑ TAS, http://www.ebi.ac.uk/QuickGO/annotations?protein=P08908&geneProductId=UniProtKB:P08908, 16 Gorffennaf 2018, Proteome Inc., Increase in serotonin-1A autoreceptors in the midbrain of suicide victims with major depression-postmortem evidence for decreased serotonin activity, GOA
- ↑ IMP, 16 Gorffennaf 2018, P08908, Role of glycosphingolipids in the function of human serotonin₁A receptors, GOA, http://www.ebi.ac.uk/QuickGO/annotations?protein=P08908&geneProductId=UniProtKB:P08908, UniProt
- ↑ IEA, http://www.ebi.ac.uk/QuickGO/annotations?protein=P08908&geneProductId=UniProtKB:P08908, 16 Gorffennaf 2018, Ensembl, GOA
- ↑ 17.0 17.1 IDA, 16 Gorffennaf 2018, P08908, Expression of 5HT1a receptors on activated human T cells. Regulation of cyclic AMP levels and T cell proliferation by 5-hydroxytryptamine, GOA, http://www.ebi.ac.uk/QuickGO/annotations?protein=P08908&geneProductId=UniProtKB:P08908, UniProt
- ↑ IPI, http://www.ebi.ac.uk/QuickGO/annotations?geneProductId=UniProtKB:P08908, 8 Ebrill 2019, Parkinsons Disease Gene Ontology Initiative, Dynamic modulation of FGFR1-5-HT1A heteroreceptor complexes. Agonist treatment enhances participation of FGFR1 and 5-HT1A homodimers and recruitment of β-arrestin2, GOA
- ↑ IPI, http://www.ebi.ac.uk/QuickGO/annotations?geneProductId=UniProtKB:P08908, 8 Ebrill 2019, IntAct protein interaction database, Fibroblast growth factor receptor 1- 5-hydroxytryptamine 1A heteroreceptor complexes and their enhancement of hippocampal plasticity, GOA
- ↑ 20.0 20.1 20.2 20.3 20.4 20.5 20.6 20.7 20.8 IBA, http://www.ebi.ac.uk/QuickGO/annotations?geneProductId=UniProtKB:P08908, 8 Ebrill 2019, GO Central, Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium, GOA
- ↑ IDA, http://www.ebi.ac.uk/QuickGO/annotations?geneProductId=UniProtKB:P08908, 8 Ebrill 2019, Parkinsons Disease Gene Ontology Initiative, Dynamic modulation of FGFR1-5-HT1A heteroreceptor complexes. Agonist treatment enhances participation of FGFR1 and 5-HT1A homodimers and recruitment of β-arrestin2, GOA
- ↑ 22.0 22.1 22.2 22.3 22.4 22.5 22.6 IEA, 8 Ebrill 2019, P08908, GOA, http://www.ebi.ac.uk/QuickGO/annotations?geneProductId=UniProtKB:P08908, UniProt
- ↑ 23.0 23.1 23.2 23.3 23.4 23.5 23.6 23.7 23.8 IEA, http://www.ebi.ac.uk/QuickGO/annotations?geneProductId=UniProtKB:P08908, 8 Ebrill 2019, InterPro, GOA
- ↑ TAS, http://www.ebi.ac.uk/QuickGO/annotations?geneProductId=UniProtKB:P08908, 8 Ebrill 2019, Proteome Inc., Increase in serotonin-1A autoreceptors in the midbrain of suicide victims with major depression-postmortem evidence for decreased serotonin activity, GOA
- ↑ 25.0 25.1 IMP, 8 Ebrill 2019, P08908, Role of glycosphingolipids in the function of human serotonin₁A receptors, GOA, http://www.ebi.ac.uk/QuickGO/annotations?geneProductId=UniProtKB:P08908, UniProt
- ↑ 26.0 26.1 26.2 26.3 26.4 26.5 26.6 IEA, http://www.ebi.ac.uk/QuickGO/annotations?geneProductId=UniProtKB:P08908, 8 Ebrill 2019, Ensembl, GOA
- ↑ 27.0 27.1 IDA, 8 Ebrill 2019, P08908, Expression of 5HT1a receptors on activated human T cells. Regulation of cyclic AMP levels and T cell proliferation by 5-hydroxytryptamine, GOA, http://www.ebi.ac.uk/QuickGO/annotations?geneProductId=UniProtKB:P08908, UniProt
- ↑ 28.0 28.1 TAS, http://www.ebi.ac.uk/QuickGO/annotations?geneProductId=UniProtKB:P08908, 8 Ebrill 2019, Reactome, GOA
- ↑ TAS, http://www.ebi.ac.uk/QuickGO/annotations?protein=P08908&geneProductId=UniProtKB:P08908, 16 Gorffennaf 2018, Proteome Inc., The genomic clone G-21 which resembles a beta-adrenergic receptor sequence encodes the 5-HT1A receptor, GOA
- ↑ IDA, 16 Gorffennaf 2018, P08908, Role of glycosphingolipids in the function of human serotonin₁A receptors, GOA, http://www.ebi.ac.uk/QuickGO/annotations?protein=P08908&geneProductId=UniProtKB:P08908, UniProt
- ↑ TAS, http://www.ebi.ac.uk/QuickGO/annotations?geneProductId=UniProtKB:P08908, 8 Ebrill 2019, Proteome Inc., The genomic clone G-21 which resembles a beta-adrenergic receptor sequence encodes the 5-HT1A receptor, GOA
- ↑ IDA, 8 Ebrill 2019, P08908, Role of glycosphingolipids in the function of human serotonin₁A receptors, GOA, http://www.ebi.ac.uk/QuickGO/annotations?geneProductId=UniProtKB:P08908, UniProt
- ↑ 33.0 33.1 TAS, http://www.ebi.ac.uk/QuickGO/annotations?geneProductId=UniProtKB:P08908, 8 Ebrill 2019, Proteome Inc., Activation of 5-HT1A receptors expressed in NIH-3T3 cells induces focus formation and potentiates EGF effect on DNA synthesis, GOA
- ↑ 34.0 34.1 34.2 34.3 34.4 34.5 ISS, 8 Ebrill 2019, P08908, GOA, http://www.ebi.ac.uk/QuickGO/annotations?geneProductId=UniProtKB:P08908, UniProt
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 8182, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 7191, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 8434, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 8436, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 8435, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 3, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 4, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 5, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 7, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 31, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 34, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 8, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 37, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 38, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 11, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 39, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 40, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 12, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 1, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 43, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 17, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 19, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 20, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 44, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 45, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 3924, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 46, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 47, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 50, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 2, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 51, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 23, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 24, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 25, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 53, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 54, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 55, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 30, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 57, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 58, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 60, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 33, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 9, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 10, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 35, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 36, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 41, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 14, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 42, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 48, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 49, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 52, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 26, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 32, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 28, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 56, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 7427, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 7351, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 59, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 62, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 83, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 84, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 85, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 86, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 87, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 68, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 88, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 7227, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 89, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 73, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 90, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 91, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 92, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 93, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 94, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 95, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 96, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 97, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 72, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 98, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 99, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 100, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 101, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 79, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 80, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 102, Saesneg
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 103, Saesneg
- ↑ Open Targets Platform, 14 Awst 2023, https://platform.opentargets.org/drug/CHEMBL1512580
- ↑ Open Targets Platform, 14 Awst 2023, https://platform.opentargets.org/drug/CHEMBL37744
- ↑ Open Targets Platform, 14 Awst 2023, https://platform.opentargets.org/drug/CHEMBL2219425
- ↑ Open Targets Platform, 14 Awst 2023, https://platform.opentargets.org/drug/CHEMBL284092
- ↑ Open Targets Platform, 14 Awst 2023, https://platform.opentargets.org/drug/CHEMBL1200399